The proliferation, migration and survival of LECs depend mainly on VEGFR2/3 signaling axis, which is driven by VEGF-C and VEGF-D (Vascular Endothelial Growth Factors –C and –D) (53, 54) produced by many different cell types, including tumor cells and immune cells. This evidence concerns the gene VEGFC and neoplasm.